Because of that delay the NRC says the opportunity to conduct the trials is over.The NRC says the Canadian Center for Vaccinology had been ready to start clinical trials as early as June, after Health Canada approved CanSino’s proposal.The Halifax lab was one of several in Canada and in the U.S.
whose work in 2014 led to an Ebola vaccine that was used in West Africa.In its statement, the NRC says it will focus on other partners and other COVID-19 priorities. .